Resources from the same session
LBA58 - A randomized phase III trial of perioperative chemotherapy (periop CT) with or without preoperative chemoradiotherapy (preop CRT) for resectable gastric cancer (AGITG TOPGEAR): Final results from an intergroup trial of AGITG, TROG, EORTC and CCTG
Presenter: Trevor Leong
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
LBA59 - Modified FOLFOX plus/minus nivolumab and ipilimumab vs FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Final results of the IKF-AIO-Moonlight trial
Presenter: Sylvie Lorenzen
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
Q&A
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Webcast
1400O - Final overall survival for the phase III, KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+ advanced, unresectable or metastatic G/GEJ adenocarcinoma
Presenter: Sara Lonardi
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
1401O - Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)
Presenter: Yelena Janjigian
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
Invited Discussant 1400O and 1401O
Presenter: Filippo Pietrantonio
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Webcast